The Royal Pharmaceutical Society of Great Britain has welcomed a move by the Medicines and Healthcare Products Regulatory Agency to reclassify azithromycin - an antibiotic used to treat chlamydia - as an over-the-counter drug.
It is the first time the agency has licensed an antibiotic for sale without a prescription. The Royal Pharmaceutical Society said the move would help improve access to chlamydia treatment.
For more details, go to www.mhra.gov.uk
A nationwide alert has been issued to hospitals after a series of incidents involving artificial breathing machines that have harmed patients.
Jonathan Bloor lists the core tenets that leaders should remember as they work towards implementing digital technologies to deliver the long-term plan
Trusts are not doing enough to review and learn from the deaths of their patients, a report from the Care Quality Commission has warned.
We are aware that some of our users are experiencing problems accessing hsj.co.uk.
To protect your security as hsj.co.uk upgrades to a new platform, your existing password will no longer work.
Financial penalties are being lifted from high-profile standards including cancer and elective waiting times, so far without attracting much attention. How is this happening? And will it work, asks Rob Findlay
No comments yet